Perioperative steroid administration reduces overall complications in patients undergoing liver resection: A meta-analysis

Table 1 Patient profile of included studies (distribution, age, sex, and pathology)

Ref.	Number		Age		Sex (M/F)		Pathology
	Steroid	Control	Steroid	Control	Steroid	Control		Steroid	Control
Donadon et al[13], 2016	16	16	65 (27-80)1	63 (22-77)1	10/6	9/7	Metastasis	6	12
							HCC	6	2
							Cholangiocarcinoma	4	0
							Others	0	2
Hasegawa et al[15], 2020	50	50	67 (59-74)2	68 (62–75)2	30/20	31/19	Metastasis	21	14
Hayashi et al[12], 2011	102	98	69 (39-81)1	70 (35-82)1	-	-	Metastasis	32	23
							HCC	63	66
							Cholangiocarcinoma	6	5
							Others	1	4
Muratore et al[20], 2003	25	28	65.4 ± 10.83	64.1 ± 11.73	8/17	11/17	-	-	-
Pulitanò et al[17], 2007	37	36	63 (31-85)4	61.8 (21-78)4	23/14	22/14	Metastasis	16	14
							HCC	12	14
							Cholangiocarcinoma	5	4
							Hemangioendothelioma	1	1
							Benign	3	3
Schmidt et al[18], 2007	10	10	575	655	3/7	4/6	HCC	2	1
							Metastasis	4	4
							Cholangiocarcinoma	0	2
							Benign	4	3
Yamashita et al[16], 2001	17	16	60.3 ± 1.86	56.8 ± 3.96	4/13	11/5	HCC	13	8
							Metastasis	0	3
							Cholangiocarcinoma	0	1
							Living donor of transplant	4	4
Zi et al[19], 2015	40	39	57.55 ± 8.813	57.51 ± 10.323	23/17	17/22	Malignant	31	34
							Benign	9	5

¹Median (range).

²Median (interquartile range).

³mean ± SD.

⁴Mean with range.

⁵Mean.

⁶mean ± SE.

M: Male; F: Female; HCC: Hepatocellular carcinoma.